{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:55:39Z","timestamp":1778824539625,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.jns.2012.03.026","type":"journal-article","created":{"date-parts":[[2012,5,11]],"date-time":"2012-05-11T04:31:59Z","timestamp":1336710719000},"page":"8-14","source":"Crossref","is-referenced-by-count":10,"title":["The nervous system's potential role in multiple sclerosis associated bone loss"],"prefix":"10.1016","volume":"319","author":[{"given":"Sowmya","family":"Josyula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bijal K.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuval","family":"Karmon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Teter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Batista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Ostroff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Weinstock-Guttman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jns.2012.03.026_bb0005","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s001980070050","article-title":"Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos)","volume":"11","author":"Tenenhouse","year":"2000","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jns.2012.03.026_bb0010","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00003086-199009000-00032","article-title":"Skeletal tissue response to cytokines","volume":"258","author":"Goldring","year":"1990","journal-title":"Clin Orthop Relat Res"},{"issue":"1\u20132","key":"10.1016\/j.jns.2012.03.026_bb0015","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cccn.2004.05.012","article-title":"Markers of bone remodeling predict rate of bone loss in multiple sclerosis patients treated with low dose glucocorticoids","volume":"348","author":"Stepan","year":"2004","journal-title":"Clin Chim Acta"},{"issue":"2","key":"10.1016\/j.jns.2012.03.026_bb0020","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1191\/1352458504ms993oa","article-title":"Risk of bone loss in men with multiple sclerosis","volume":"10","author":"Weinstock-Guttman","year":"2004","journal-title":"Mult Scler"},{"issue":"13","key":"10.1016\/j.jns.2012.03.026_bb0025","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM200009283431301","article-title":"Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis","volume":"343","author":"Jacobs","year":"2000","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jns.2012.03.026_bb0030","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/sj.ejcn.1600870","article-title":"The influence of smoking on vitamin D status and calcium metabolism","volume":"53","author":"Brot","year":"1999","journal-title":"Eur J Clin Nutr"},{"issue":"3","key":"10.1016\/j.jns.2012.03.026_bb0035","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00415-009-5337-6","article-title":"Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis","volume":"257","author":"Steffensen","year":"2010","journal-title":"J Neurol"},{"issue":"6","key":"10.1016\/j.jns.2012.03.026_bb0040","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1191\/1352458503ms966oa","article-title":"Bone status in multiple sclerosis: beyond corticosteroids","volume":"9","author":"T\u00fcz\u00fcn","year":"2003","journal-title":"Mult Scler"},{"issue":"6","key":"10.1016\/j.jns.2012.03.026_bb0045","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1682\/JRRD.2007.10.0159","article-title":"Bone health in ambulatory individuals with multiple sclerosis: impact of physical activity, glucocorticoid use, and body composition","volume":"45","author":"Mojtahedi","year":"2008","journal-title":"J Rehabil Res Dev"},{"issue":"23","key":"10.1016\/j.jns.2012.03.026_bb0050","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1212\/WNL.0b013e3181e1cec2","article-title":"A phase I\/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis","volume":"74","author":"Burton","year":"2010","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jns.2012.03.026_bb0055","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00198-003-1562-5","article-title":"Risk factors for low bone mineral density and the 6-year rate of bone loss among premenopausal and perimenopausal women","volume":"15","author":"Bainbridge","year":"2004","journal-title":"Osteoporos Int"},{"issue":"7","key":"10.1016\/j.jns.2012.03.026_bb0060","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1468-1331.2005.00988.x","article-title":"Long\u2010term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosis","volume":"12","author":"Zorzon","year":"2005","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.jns.2012.03.026_bb0065","first-page":"4","article-title":"Regulatory T cells: back to the future","volume":"64","author":"Damoiseaux","year":"2006","journal-title":"Neth J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.jns.2012.03.026_bb0070","first-page":"S2","article-title":"The healthy immune system vs the MS immune system","volume":"74","author":"Multiple sclerosis immunology","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2012.03.026_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002239900570","article-title":"Bone and cytokines: beyond IL-1, IL-6 and TNF-a","volume":"64","author":"Rifas","year":"1999","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"10.1016\/j.jns.2012.03.026_bb0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jns.2008.08.031","article-title":"The role of osteopontin: a shared pathway in the pathogenesis of multiple sclerosis and osteoporosis?","volume":"276","author":"Alt\u0131nta\u015f","year":"2009","journal-title":"J Neurol Sci"},{"issue":"2","key":"10.1016\/j.jns.2012.03.026_bb0085","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI200319190","article-title":"Osteopontin: a bridge between bone and the immune system","volume":"112","author":"Gravallese","year":"2003","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.jns.2012.03.026_bb0090","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/1352458509359723","article-title":"Increased osteopontin plasma levels in multiple sclerosis patients correlate with bone-specific markers","volume":"16","author":"Vogt","year":"2010","journal-title":"Mult Scler"},{"issue":"3","key":"10.1016\/j.jns.2012.03.026_bb0095","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1172\/JCI115072","article-title":"1, 25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis","volume":"87","author":"Lemire","year":"1991","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.jns.2012.03.026_bb0100","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1212\/01.WNL.0000101723.79681.38","article-title":"Vitamin D intake and incidence of multiple sclerosis","volume":"62","author":"Munger","year":"2004","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jns.2012.03.026_bb0105","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/abbi.1999.1605","article-title":"Expression of 1,25-dihydroxyvitamin D3 receptor in the immune system","volume":"374","author":"Veldman","year":"2000","journal-title":"Arch Biochem Biophys"},{"issue":"1\u20132","key":"10.1016\/j.jns.2012.03.026_bb0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jneuroim.2007.11.014","article-title":"Vitamin D as an immune modulator in multiple sclerosis, a review","volume":"194","author":"Smolders","year":"2008","journal-title":"J Neuroimmunol"},{"issue":"6882","key":"10.1016\/j.jns.2012.03.026_bb0115","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/416744a","article-title":"RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-\u03b2","volume":"416","author":"Takayanagi","year":"2002","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jns.2012.03.026_bb0120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11845-008-0253-9","article-title":"Favorable effect of immunomodulator therapy on bone mineral density in multiple sclerosis","volume":"178","author":"Shuhaibar","year":"2009","journal-title":"Ir J Med Sci"},{"issue":"2","key":"10.1016\/j.jns.2012.03.026_bb0240","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1210\/er.2007-0014","article-title":"Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease","volume":"29","year":"2008","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.jns.2012.03.026_bb0130","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/1352458506070605","article-title":"Interferon-\u03b2 modulates bone-associated cytokines and osteoclast precursor activity in multiple sclerosis patients","volume":"12","author":"Weinstock-Guttman","year":"2006","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2012.03.026_bb0245","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev.physiol.62.1.413","volume":"62","author":"Leptin","year":"2000","journal-title":"Annu Rev Physiol"},{"issue":"5","key":"10.1016\/j.jns.2012.03.026_bb0140","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nri1350","article-title":"The weight of leptin in immunity","volume":"4","author":"La Cava","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.jns.2012.03.026_bb0145","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1172\/JCI26523","article-title":"Leptin neutralization interferes with pathogenic T cell autoreactivity in autoimmune encephalomyelitis","volume":"116","author":"De Rosa","year":"2006","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.jns.2012.03.026_bb0150","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.4049\/jimmunol.166.10.5909","article-title":"Requirement for leptin in the induction and progression of autoimmune encephalomyelitis","volume":"166","author":"Matarese","year":"2001","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.jns.2012.03.026_bb0155","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1210\/en.140.6.2755","article-title":"Regulation of neuronal and glial proteins by leptin: implications for brain development","volume":"140","author":"Ahima","year":"1999","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.jns.2012.03.026_bb0160","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0092-8674(00)81558-5","article-title":"Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass","volume":"100","author":"Ducy","year":"2000","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.jns.2012.03.026_bb0165","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/sj.embor.7400254","article-title":"Enhanced bone formation in lipodystrophic PPAR\u03b3 hyp\/hyp mice relocates haematopoiesis to the spleen","volume":"5","author":"Cock","year":"2004","journal-title":"EMBO Rep"},{"issue":"10","key":"10.1016\/j.jns.2012.03.026_bb0170","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.1074\/jbc.272.10.6093","article-title":"The leptin receptor","volume":"272","author":"Tartaglia","year":"1997","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.jns.2012.03.026_bb0175","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0092-8674(02)01049-8","article-title":"Leptin regulates bone formation via the sympathetic nervous system","volume":"111","author":"Takeda","year":"2002","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.jns.2012.03.026_bb0180","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1359\/jbmr.2002.17.10.1896","article-title":"Relationship of serum leptin concentration with bone mineral density in the United States population","volume":"17","author":"Ruhl","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1016\/j.jns.2012.03.026_bb0185","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1365-2826.2008.01732.x","article-title":"Central control of bone remodelling","volume":"20","author":"Takeda","year":"2008","journal-title":"J Neuroendocrinol"},{"issue":"9","key":"10.1016\/j.jns.2012.03.026_bb0190","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJM200008313430911","article-title":"New treatments for reflex sympathetic dystrophy","volume":"343","author":"Schwartzman","year":"2000","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jns.2012.03.026_bb0250","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.1210\/jc.2005-0573","article-title":"Effects of a beta-blocker on bone turnover in normal postmenopausal women: a randomized controlled trial","volume":"90","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jns.2012.03.026_bb0200","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cmet.2010.01.005","article-title":"Signaling through the M3 muscarinic receptor favors bone mass accrual by decreasing sympathetic activity","volume":"11","author":"Shi","year":"2010","journal-title":"Cell Metab"},{"issue":"10","key":"10.1016\/j.jns.2012.03.026_bb0205","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/nm1640","article-title":"Central control of bone remodeling by neuromedin U","volume":"13","author":"Sato","year":"2007","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.jns.2012.03.026_bb0210","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.cell.2005.06.028","article-title":"The molecular clock mediates leptin-regulated bone formation","volume":"122","author":"Fu","year":"2005","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.jns.2012.03.026_bb0215","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.npep.2004.05.005","article-title":"NPY and Y receptors: lessons from transgenic and knockout models","volume":"38","author":"Lin","year":"2004","journal-title":"Neuropeptides"},{"issue":"9","key":"10.1016\/j.jns.2012.03.026_bb0220","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1359\/JBMR.040606","article-title":"Serotonin regulates osteoclast differentiation through its transporter","volume":"19","author":"Battaglino","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.jns.2012.03.026_bb0225","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.cell.2009.06.051","article-title":"A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure","volume":"138","author":"Yadav","year":"2009","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.jns.2012.03.026_bb0230","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.4049\/jimmunol.137.11.3544","article-title":"Recombinant human interferon-gamma inhibits formation of human osteoclast-like cells","volume":"137","author":"Takahashi","year":"1986","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.jns.2012.03.026_bb0235","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.4049\/jimmunol.136.7.2478","article-title":"Actions of recombinant interleukin 1, interleukin 2, and interferon-gamma on bone resorption in vitro","volume":"136","author":"Gowen","year":"1986","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.jns.2012.03.026_bb0255","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1172\/JCI11232","article-title":"Expression of IL-5 alters bone metabolism and induces ossification of the spleen in transgenic mice","volume":"107","author":"Macias","year":"2001","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.jns.2012.03.026_bb0260","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/art.33446","article-title":"IL-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts","volume":"64","author":"Kim","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.jns.2012.03.026_bb0265","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000334095","article-title":"Fluoxetine promotes remission in acute experimental autoimmune encephalomyelitis in rats","volume":"19","author":"Yuan","year":"2012","journal-title":"Neuroimmunomodulation"},{"issue":"2","key":"10.1016\/j.jns.2012.03.026_bb0270","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000321634","article-title":"The immunomodulatory effect of the antidepressant sertraline in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis","volume":"18","author":"Taler","year":"2011","journal-title":"Neuroimmunomodulation"},{"issue":"1\u20132","key":"10.1016\/j.jns.2012.03.026_bb0275","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jneuroim.2010.11.008","article-title":"Vitamin D has a direct immunomodulatory effect on CD8+ T cells of patients with early multiple sclerosis and healthy control subjects","volume":"233","author":"Lysandropoulos","year":"2011","journal-title":"J Neuroimmunol"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X12001670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X12001670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T17:08:17Z","timestamp":1687453697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X12001670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":52,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0022510X12001670"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2012.03.026","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}